| Schedule of effect of the restatement on each financial statement line item |
| | | | | | | | | | | | June 30, 2025 | | | | June 30, 2025 | | | As Reported | | Adj. | | As Restated | Deemed Dividend Series A Preferred Warrant | | $ | (35,399,000) | | $ | 2,153,000 | | $ | (33,246,000) | Deemed Dividend Series A Warrant | | $ | (3,270,000) | | $ | 243,000 | | $ | (3,027,000) | | | | | | | | | | | Net loss per common share - continuing ops | | | (40,928,462) | | | 2,396,000 | | $ | (38,532,462) | | | | | | | | | | | Basic and Diluted loss per common share - continuing ops | | $ | (1.58) | | $ | 0.09 | | $ | (1.49) | | | | | | | | | | | Basic and Diluted loss per common share | | $ | (1.29) | | $ | 0.09 | | $ | (1.20) |
| | | | | | | | | | | | June 30, 2025 | | | | June 30, 2025 | | | As Reported | | Adj. | | As Restated | Deemed Dividend Series A Preferred Warrant | | $ | (43,754,824) | | $ | 2,153,000 | | $ | (41,601,824) | Deemed Dividend Series A Warrant | | $ | (3,270,000) | | $ | 243,000 | | $ | (3,027,000) | | | | | | | | | | | Net loss per common share - continuing ops | | | (50,758,994) | | | 2,396,000 | | $ | (48,362,994) | | | | | | | | | | | Basic and Diluted loss per common share - continuing ops | | $ | (3.73) | | $ | 0.18 | | $ | (3.55) | | | | | | | | | | | Basic and Diluted loss per common share | | $ | (3.26) | | $ | 0.18 | | $ | (3.08) |
| | | | | | | | | June 30, 2025 | | | | June 30, 2025 | | | As Reported | | Adj. | | As Restated | Supplemental disclosure of cash flows information | | | | | | | Deemed dividend on Series A Preferred Warrants | | 43,754,824 | | (2,153,000) | | 41,601,824 | Deemed dividend on Series A Warrants | | 3,270,000 | | (243,000) | | 3,027,000 |
|